Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Analysis & Investment Frameworks

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock analysis on Invetso. Review Shuttle Pharmaceuticals Holdings, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Shuttle Pharmaceuticals Holdings, Inc. Company Overview

Shuttle Pharmaceuticals Holdings, Inc. Key Financial Metrics

About Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Shuttle Pharmaceuticals Holdings, Inc. Investment Frameworks

Invetso analyzes Shuttle Pharmaceuticals Holdings, Inc. (SHPH) across the following frameworks:

Explore More SHPH Research